These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 9869464

  • 1. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Capeans C, De Rojas MV, Lojo S, Salorio MS.
    Retina; 1998; 18(6):546-50. PubMed ID: 9869464
    [Abstract] [Full Text] [Related]

  • 2. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM, Struyf S, Kangave D, Geboes K, Van Damme J.
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [Abstract] [Full Text] [Related]

  • 3. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M, Kabatas EU, Batman C, Akin KO, Kabatas N.
    Ophthalmic Res; 2012 Sep; 47(1):7-12. PubMed ID: 21691136
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of RAGE and its ligands in proliferative retinal disease.
    Pachydaki SI, Tari SR, Lee SE, Ma W, Tseng JJ, Sosunov AA, Cataldergirmen G, Scarmeas N, Caspersen C, Chang S, Schiff WM, Schmidt AM, Barile GR.
    Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
    [Abstract] [Full Text] [Related]

  • 5. Soluble TNF receptors in vitreoretinal proliferative disease.
    Limb GA, Hollifield RD, Webster L, Charteris DG, Chignell AH.
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
    [Abstract] [Full Text] [Related]

  • 6. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
    Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH.
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders.
    Abu el-Asrar AM, Van Damme J, Put W, Veckeneer M, Dralands L, Billiau A, Missotten L.
    Am J Ophthalmol; 1997 May; 123(5):599-606. PubMed ID: 9152065
    [Abstract] [Full Text] [Related]

  • 9. Vitreous Chemokines and Sho (Zheng in Chinese) of Chinese-Korean-Japanese medicine in patients with diabetic vitreoretinopathy.
    Hayasaka S, Zhang XY, Cui HS, Yanagisawa S, Chi ZL, Hayasaka Y, Shimada Y.
    Am J Chin Med; 2006 May; 34(4):537-43. PubMed ID: 16883625
    [Abstract] [Full Text] [Related]

  • 10. Aqueous levels of macrophage migration inhibitory factor and monocyte chemotactic protein-1 in patients with diabetic retinopathy.
    Tashimo A, Mitamura Y, Nagai S, Nakamura Y, Ohtsuka K, Mizue Y, Nishihira J.
    Diabet Med; 2004 Dec; 21(12):1292-7. PubMed ID: 15569131
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
    Watanabe D, Suzuma K, Suzuma I, Ohashi H, Ojima T, Kurimoto M, Murakami T, Kimura T, Takagi H.
    Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
    [Abstract] [Full Text] [Related]

  • 13. Interleukin-8, monocyte chemoattractant protein-1 and IL-10 in the vitreous fluid of patients with proliferative diabetic retinopathy.
    Hernández C, Segura RM, Fonollosa A, Carrasco E, Francisco G, Simó R.
    Diabet Med; 2005 Jun; 22(6):719-22. PubMed ID: 15910622
    [Abstract] [Full Text] [Related]

  • 14. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH, Occleston NL, Aylward GW, Khaw PT.
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [Abstract] [Full Text] [Related]

  • 15. CC chemokine concentrations increase in respiratory distress syndrome and correlate with development of bronchopulmonary dysplasia.
    Baier RJ, Majid A, Parupia H, Loggins J, Kruger TE.
    Pediatr Pulmonol; 2004 Feb; 37(2):137-48. PubMed ID: 14730659
    [Abstract] [Full Text] [Related]

  • 16. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
    Itakura H, Kishi S, Kotajima N, Murakami M.
    Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
    [Abstract] [Full Text] [Related]

  • 17. Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Elner SG, Elner VM, Jaffe GJ, Stuart A, Kunkel SL, Strieter RM.
    Curr Eye Res; 1995 Nov; 14(11):1045-53. PubMed ID: 8585935
    [Abstract] [Full Text] [Related]

  • 18. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
    Yeh PT, Yang CM, Huang JS, Chien CT, Yang CH, Chiang YH, Shih YF.
    Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
    [Abstract] [Full Text] [Related]

  • 19. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
    Limb GA, Chignell AH, Cole CJ, Green WT, Webster L, Hollifield RD, Dumonde DC.
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
    [Abstract] [Full Text] [Related]

  • 20. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY, Shen LJ, Zhao KK, Song ZM, Qu J.
    Ophthalmic Res; 2009 Apr; 42(3):138-40. PubMed ID: 19602911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.